Showing results (591-600 of 789) with videos related to
Sort By:
Pageof 79
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapyP Hadji, C Jackisch, W Bolten, et al.Experimental and Molecular Pathology|June 27, 2015
S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancerMelanie Maierthaler, Mark Kriegsmann, Cike Peng, et al.Breast (Edinburgh, Scotland)|May 2, 2021
Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008-2017Fabian Riedel, Ann Sophie Hoffmann, Mareike Moderow, et al.Insights Into Imaging|August 7, 2024
Shear-wave elastography as a supplementary tool for axillary staging in patients undergoing breast cancer diagnosisRiku Togawa, Fabian Riedel, Manuel Feisst, et al.Frontiers in Cell and Developmental Biology|September 14, 2020
Annexin A7 Regulates Endometrial ReceptivityMd Alauddin, Madhuri S Salker, Anja T Umbach, et al.Breast Cancer Research and Treatment|May 22, 2020
HER2-targeted therapy influences CTC status in metastatic breast cancerThomas M Deutsch, Sabine Riethdorf, Carlo Fremd, et al.Gynecologic Oncology|May 23, 2017
Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trialC Dinkic, M Eichbaum, M Schmidt, et al.Molecular Human Reproduction|September 18, 2013
TGFβ1 and SGK1-sensitive store-operated Ca2+ entry and Orai1 expression in endometrial Ishikawa cellsS Schmidt, S Schneider, W Yang, et al.Oncoimmunology|March 5, 2016
Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patientsCarlo Fremd, Stefan Stefanovic, Philipp Beckhove, et al.The Prostate|January 15, 2015
Significance of apoptotic and non-apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancerTilman Todenhöfer, Jörg Hennenlotter, Frank Faber, et al.Pageof 79